<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03499314</url>
  </required_header>
  <id_info>
    <org_study_id>17-00522</org_study_id>
    <nct_id>NCT03499314</nct_id>
  </id_info>
  <brief_title>A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS)</brief_title>
  <official_title>A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, double-blind pilot clinical trial to test a novel treatment approach to&#xD;
      rehabilitate fine motor function in individuals living with progressive multiple sclerosis&#xD;
      (MS) using anodal transcranial direct current stimulation (tDCS) to augment manual dexterity&#xD;
      training. Treatment will be delivered to individuals at home using a state-of-the-art&#xD;
      remotely supervised tele-rehabilitation protocol, a major advantage for patients with respect&#xD;
      to ease of access, feasibility, reinforcement learning and minimal burden of in clinic study&#xD;
      visit participation. Improvements in fine motor skill will be assessed at each remote session&#xD;
      using a novel portable grip device that measures execution and adaptation or learning of&#xD;
      fingertip forces during grasp, which is more sensitive than standard measures of hand&#xD;
      function.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 15, 2018</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Temporal coordination between grasping and lifting force using the preload phase duration (PLD)</measure>
    <time_frame>30 Minutes</time_frame>
    <description>(PLD) is the duration of finger contact until the onset of positive load force. It assesses the time taken to stabilize grasp and is a robust measure of grasp execution.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>RS-tDCS Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 times 20 minute stimulation session supervised by a study technician through a videoconferencing platform, VSee</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Stimulation</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20 ×20-minute sessions sham tDCS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active RS-tDCS +At-Home Manual Dexterity Training</intervention_name>
    <description>Bilateral M1-SO electrode placement; Active= anodal 2.0 mA dose × 20 minutes</description>
    <arm_group_label>RS-tDCS Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham RS-tDCS +At-Home Manual Dexterity Training</intervention_name>
    <description>Designed to ensure blinding, includes initial and ending &quot;ramp-up/down&quot; stimulation for 60 seconds</description>
    <arm_group_label>Sham Stimulation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Manual dexterity training</intervention_name>
    <description>Manual dexterity training will be based on the at-home study in MS by Kamm and colleagues, where the training was completed by participants in their homes and demonstrated to be superior to strength training.</description>
    <arm_group_label>RS-tDCS Stimulation</arm_group_label>
    <arm_group_label>Sham Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Definite MS diagnosis, progressive subtype&#xD;
&#xD;
          -  9HPT score between -1.0 and -4.0 standard deviations from age-based normative data&#xD;
&#xD;
          -  Score of &lt; 7.5 or less on the EDSS (with caregiver proxy required for those with&#xD;
             scores of 6.5 or greater)*&#xD;
&#xD;
          -  Ability to understand the informed consent process and provide consent to participate&#xD;
             in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Primary neurologic, psychiatric or other medical disorder other than MS&#xD;
&#xD;
          -  Use of upper extremity Botox injection within 3 months&#xD;
&#xD;
          -  Current use of intrathecal Baclofen&#xD;
&#xD;
          -  History of seizure disorder&#xD;
&#xD;
          -  History of head trauma or medical device in head or neck&#xD;
&#xD;
          -  Clinically significant abnormality on EKG&#xD;
&#xD;
          -  Symbol Digit Modalities Test or SDMT score ≥3.0 SD from published norms&#xD;
&#xD;
          -  WRAT-4 reading level below average (&lt;85) (estimated general intellectual function)&#xD;
&#xD;
          -  Skin disorder/sensitive near stimulation locations&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leigh Charvet, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York University School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>April 9, 2018</study_first_submitted>
  <study_first_submitted_qc>April 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2018</study_first_posted>
  <last_update_submitted>December 1, 2020</last_update_submitted>
  <last_update_submitted_qc>December 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anodal transcranial stimulation (tDCS)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis, Chronic Progressive</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

